GlassScriptPhysician profile
Chima C Nwaukwa
NPI 1477657807
$34,821.38
in general payments reported to CMS, 2019-2025
29 companies · $1,440 in 2025
The $1,440 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,534 · 2020: $1,316 · 2021: $1,387 · 2022: $896 · 2023: $22K · 2024: $5,456 · 2025: $1,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $5,389 · Food and Beverage: $4,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,620.00 |
| Travel and Lodging | $5,388.69 |
| Food and Beverage | $4,680.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $25,780.38 | 2021-2025 | Verquvo, Capvaxive |
| Boston Scientific Corporation | $3,014.96 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Latitude Communicator Power Supply, Emblem Mri S-Icd |
| Shockwave Medical, INC | $1,240.10 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $780.05 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $580.51 | 2019-2025 | Aveir, Diamondback Peripheral |
| Novartis Pharmaceuticals Corporation | $466.09 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $441.63 | 2019-2025 | Lifevest |
| Pfizer INC. | $297.62 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $295.66 | 2019-2025 | Lokelma, Farxiga |
| Janssen Pharmaceuticals, INC | $278.96 | 2019-2024 | Xarelto |
| Cardiovascular Systems INC. | $229.33 | 2019-2021 | |
| Amarin Pharma, INC. | $219.03 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $133.43 | 2019-2024 | Camzyos |
| Sanofi-Aventis U.S. LLC | $123.19 | 2019-2023 | |
| Kestra Medical Technology Services, INC. | $119.15 | 2025 | Assure Wcd |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $106.83 | 2021 | |
| Esperion Therapeutics, INC. | $102.13 | 2021-2024 | Nexletol |
| Amgen INC. | $99.15 | 2019-2023 | Repatha |
| Gilead Sciences, INC. | $98.27 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.91 | 2019-2023 | Jardiance |
| Medtronic, INC. | $66.33 | 2022-2024 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Arbor Pharmaceuticals, INC. | $52.94 | 2021 | |
| Siemens Medical Solutions USA, INC. | $51.31 | 2020 | |
| Angiodynamics, INC. | $50.33 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Medtronic Vascular, INC. | $46.51 | 2019-2020 | |
| Novo Nordisk INC | $31.37 | 2021-2024 | Wegovy |
| Lexicon Pharmaceuticals, INC. | $17.26 | 2023 | Inpefa |
| Cleerly, INC. | $16.51 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Tactile Systems Technology INC | $14.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chima Nwaukwa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.